IBERSOL | Integrated Management Report | 2025

INTEGRATED MANAGEMENT REPORT 2025 The consideration transferred in the acquisition is measured at fair value, as are the identifiable net assets acquired. Any good- will arising is tested annually for impairment. Any gain on a purchase at a low price is recognized immediately in the income statement. Transaction costs are recognized as an expense, unless related to the issue of debt or equity securities. Any contingent consideration is measured at fair value on the acquisition date. The obligation to pay contingent consideration covered by the definition of financial instruments is classified as a financial liability or as equity based on the definitions of an equity instrument and a financial liability. Judgments and estimates Under IFRS 3, in a business combination, the acquirer must recognize and measure in the consolidated financial statements the assets acquired and liabilities assumed at fair value on the acquisition date. The level of judgment inherent in determining such fair values means that this is considered a significant accounting estimate. The fair value of the assets acquired and liabilities assumed was determined internally using the discounted cash flow method or other fair value determination techniques, which are based on the use of assumptions including macroeconomic indicators such as inflation rates, interest rates, discount rates and business projections. The determination of fair values is therefore subject to various assumptions and judgments, so changes could result in different impacts on recognized assets and results. Acquisition of subsidiary In July 2024, the acquisition of 60% of the share capital of the Spanish company Medfood Invest S.L. (Medfood), which indirectly operates 31 KFC restaurants in Spain through its subsidiary New Restaurantes of Spain, S.A., was completed. As a result, the Ibersol Group’s stake in Medfood increased from 40% to 100% (see note 6.7 associated companies note), and the Group now has control of this subsidiary. The remuneration transferred amounted to 13.4 million euros. No contingent consideration was established. The net consideration transferred amounted to 11.6 million euros, after deducting around 1.9 million euros of cash and cash equivalents from Medfood. By the end of 2024, the PPA was completed with the calculation of the fair values of the assets, liabilities and contingent liabilities acquired, resulting in goodwill for this acquisition of 4,195,902 euros (note 6.2.). Goodwill was calculated as follows: 411